Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design
Sepsis is a devastating clinical condition that can lead to multiple organ failure and death. Despite advancements in our understanding of molecular mechanisms underlying sepsis and sepsis-associated multiple organ failure, no effective therapeutic treatment to directly counteract it has yet been es...
Main Authors: | Matthijs Luxen, Matijs van Meurs, Grietje Molema |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.867625/full |
Similar Items
-
Commentary: Precision Immunotherapy for Sepsis
by: Jan G. Zijlstra, et al.
Published: (2019-01-01) -
Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function
by: Wang YF, et al.
Published: (2022-06-01) -
Kidney histopathology in lethal human sepsis
by: Adnan Aslan, et al.
Published: (2018-12-01) -
Sepsis-induced coagulopathy and disseminated intravascular coagulation
by: Antonino Giarratano
Published: (2022-07-01) -
Pharmacological inhibition of protein tyrosine kinases axl and fyn reduces TNF-α-induced endothelial inflammatory activation in vitro
by: Sophie F. Ellermann, et al.
Published: (2022-12-01)